PMC:7306567 / 28398-28710 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":121,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T37","span":{"begin":121,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A37","pred":"uberon_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-PubTator","denotations":[{"id":"316","span":{"begin":300,"end":311},"obj":"Chemical"}],"attributes":[{"id":"A316","pred":"tao:has_database_id","subj":"316","obj":"MESH:D053139"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T126","span":{"begin":3,"end":12},"obj":"Disease"},{"id":"T127","span":{"begin":145,"end":154},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T197","span":{"begin":206,"end":211},"obj":"Chemical"},{"id":"T199","span":{"begin":266,"end":290},"obj":"Chemical"},{"id":"T200","span":{"begin":280,"end":290},"obj":"Chemical"},{"id":"T201","span":{"begin":300,"end":311},"obj":"Chemical"}],"attributes":[{"id":"A197","pred":"chebi_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/CHEBI_16474"},{"id":"A198","pred":"chebi_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/CHEBI_57783"},{"id":"A199","pred":"chebi_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/CHEBI_52425"},{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-sentences","denotations":[{"id":"T208","span":{"begin":0,"end":312},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T260","span":{"begin":121,"end":127},"obj":"UBERON:0000479"},{"id":"T261","span":{"begin":159,"end":165},"obj":"UBERON:0002405"},{"id":"T262","span":{"begin":166,"end":176},"obj":"GO:0065007"},{"id":"T263","span":{"begin":220,"end":227},"obj":"GO:0043020"},{"id":"T264","span":{"begin":280,"end":290},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T265","span":{"begin":300,"end":311},"obj":"CHEBI:7798;CHEBI:7798"}],"text":"In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir."}